Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Space Condos to Lift Your Metropolitan Living - 2Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- 3She was the ultimate '90s fitness influencer. Now she's delivering Uber Eats — and rebuilding her life.
- 4SpaceX shatters its rocket launch record yet again — 165 orbital flights in 2025
- 5Lucky airplane passengers capture NASA's Artemis 2 moon launch from the sky
- SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- Tragedy in Minnesota, vaccine news, Snoop's game call: Week in review
- Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
- Hot Electric Vehicles for 2023
- 'A perfect storm': Airlines cut flights and increase airfares as jet fuel price spikes
- Manual for Conservative SUVs For Seniors
- Nvidia Share Price Could Be Hit Hard By Iran War
- This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- Genetic study identifies earliest-known dog, dating to 15,800 years ago
